193 related articles for article (PubMed ID: 35012125)
1. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
2. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
3. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
5. Development of Statistically Optimized Piperine-Loaded Polymeric Nanoparticles for Breast Cancer: In Vitro Evaluation and Cell Culture Studies.
Gilani SJ; Bin-Jumah MN; Fatima F
ACS Omega; 2023 Nov; 8(46):44183-44194. PubMed ID: 38027324
[TBL] [Abstract][Full Text] [Related]
6. Polycaprolactone based pharmaceutical nanoemulsion loaded with acriflavine: optimization and
Nawaz T; Iqbal M; Khan BA; Ahmed N; Nawaz A; Rasul A; Rizg WY; Jali AM; Ahmed RA; Safhi AY
Drug Deliv; 2022 Dec; 29(1):3233-3244. PubMed ID: 36299245
[TBL] [Abstract][Full Text] [Related]
7. Box-Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride.
Mahmoud BS; McConville C
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111756
[TBL] [Abstract][Full Text] [Related]
8. Poly ɛ-caprolactone nanoparticles loaded with Uncaria tomentosa extract: preparation, characterization, and optimization using the Box-Behnken design.
Ribeiro AF; de Oliveira Rezende RL; Cabral LM; de Sousa VP
Int J Nanomedicine; 2013; 8():431-42. PubMed ID: 23378765
[TBL] [Abstract][Full Text] [Related]
9. Optimization of valsartan encapsulation in biodegradables polyesters using Box-Behnken design.
Sadoun O; Rezgui F; G'Sell C
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():189-197. PubMed ID: 29853082
[TBL] [Abstract][Full Text] [Related]
10. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
Ravi PR; Vats R; Dalal V; Gadekar N; N A
Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
[TBL] [Abstract][Full Text] [Related]
11. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
Girgis GNS
Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
[TBL] [Abstract][Full Text] [Related]
12. Cilnidipine loaded poly (ε-caprolactone) nanoparticles for enhanced oral delivery: optimization using DoE, physical characterization, pharmacokinetic, and pharmacodynamic evaluation.
Diwan R; Ravi PR; Agarwal SI; Aggarwal V
Pharm Dev Technol; 2021 Mar; 26(3):278-290. PubMed ID: 33319618
[TBL] [Abstract][Full Text] [Related]
13. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-Coated PLGA Nanoparticles Loaded with
Azzazy HME; Fahmy SA; Mahdy NK; Meselhy MR; Bakowsky U
Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578755
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics.
Kumar A; Sawant K
Cancer Nanotechnol; 2013; 4(4-5):57-71. PubMed ID: 26069501
[TBL] [Abstract][Full Text] [Related]
16. Tofacitinib Citrate-loaded Nanoparticle Gel for the Treatment of Alopecia Areata: Response Surface Design, Formulation and
Kuchukuntla M; Palanivel V; Madhubabu A
Recent Adv Drug Deliv Formul; 2023; 17(4):314-331. PubMed ID: 38031780
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
[TBL] [Abstract][Full Text] [Related]
18. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
19. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design.
Ghasemian E; Vatanara A; Rouholamini Najafabadi A; Rouini MR; Gilani K; Darabi M
Daru; 2013 Dec; 21(1):68. PubMed ID: 24355133
[TBL] [Abstract][Full Text] [Related]
20. Novel self-assembled amphiphilic poly(epsilon-caprolactone)-grafted-poly(vinyl alcohol) nanoparticles: hydrophobic and hydrophilic drugs carrier nanoparticles.
Sheikh FA; Barakat NA; Kanjwal MA; Aryal S; Khil MS; Kim HY
J Mater Sci Mater Med; 2009 Mar; 20(3):821-31. PubMed ID: 19020953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
